Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.

Source:http://linkedlifedata.com/resource/pubmed/id/15197261

Proc. Natl. Acad. Sci. U.S.A. 2004 Jun 22 101 25 9363-8

Download in:

View as

Triples

General Info

PMID
15197261